| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 27, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 27, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 27, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 27, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 7, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 21, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 21, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 21, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 21, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Feb 14, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Feb 14, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Feb 14, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Feb 14, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 14, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 14, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 14, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 14, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 25, 2025 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 25, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 25, 2025 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Jan 17, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jan 17, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 11, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 11, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 11, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 11, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 11, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 11, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 10, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 10, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 22, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 22, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 22, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 22, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 12, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 12, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 12, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 12, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 12, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 12, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 12, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 12, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 9, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 9, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 9, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 9, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jul 15, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 15, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 15, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 15, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.062 | Jun 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.062 | Jun 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.062 | Jun 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.062 | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.076 | Mar 31, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.076 | Mar 31, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.076 | Mar 31, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.076 | Mar 31, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 4, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 4, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 4, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 4, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.066 | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.066 | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.066 | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.066 | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.067 | Sep 30, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.067 | Sep 30, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.067 | Sep 30, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 0.067 | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 21, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 21, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 17, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 17, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 27, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 7, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 7, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 7, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 7, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 7, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 7, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 7, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 7, 2023 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Diquat | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endothall | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endothall | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endothall | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Glyphosate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Dec 10, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 10, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 10, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Dec 10, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 11, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 11, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 11, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Oct 11, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 9, 2021 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 9, 2021 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Sep 7, 2021 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 9, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 9, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 5, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 5, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 29, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 29, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 29, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 29, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 29, 2021 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 1, 2021 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Surface Water Treatment Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Surface Water Treatment Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | May 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | May 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 24, 2021 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 24, 2021 | Active | N/A |